DRUG TARGETING IN CYTOMEGALOVIRUS RETINIT IS - INTRAVITREAL IMPLANTATION OF GANCICLOVIR MEDICAMENT VEHICLES - DEVELOPMENT, INDICATION, TECHNIQUES, CLINICAL-RESULTS, AND FUTURE USES
Hoc. Gumbel et Fh. Koch, DRUG TARGETING IN CYTOMEGALOVIRUS RETINIT IS - INTRAVITREAL IMPLANTATION OF GANCICLOVIR MEDICAMENT VEHICLES - DEVELOPMENT, INDICATION, TECHNIQUES, CLINICAL-RESULTS, AND FUTURE USES, Der Ophthalmologe, 95(1), 1998, pp. 58-63